R&D Adiponectin Elisa Kit
Lab Reagents
Adiponectin Elisa Laboratories manufactures the r&d adiponectin elisa kit reagents distributed by Genprice. The R&D Adiponectin Elisa Kit reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact adiponectin elisa. Other R&D products are available in stock. Specificity: R&D Category: Adiponectin Group: Elisa Kit
(R)-Lisofylline |
|||
| C4158-1 | ApexBio | 1 mg | EUR 154.8 |
|
Description: Lisofylline (LSF) is a potent anti-inflammatory agent. LSF is a chiral metabolite of pentoxifylline. (R)-LSF is the biologically active isomer of LSF [1]. |
|||
(R)-Lisofylline |
|||
| C4158-10 | ApexBio | 10 mg | EUR 822 |
|
Description: Lisofylline (LSF) is a potent anti-inflammatory agent. LSF is a chiral metabolite of pentoxifylline. (R)-LSF is the biologically active isomer of LSF [1]. |
|||
(R)-Lisofylline |
|||
| C4158-5 | ApexBio | 5 mg | EUR 489.6 |
|
Description: Lisofylline (LSF) is a potent anti-inflammatory agent. LSF is a chiral metabolite of pentoxifylline. (R)-LSF is the biologically active isomer of LSF [1]. |
|||
Granuliberin R |
|||
| 5-01251 | CHI Scientific | 4 x 5mg | Ask for price |
Ranatensin R |
|||
| 5-01868 | CHI Scientific | 4 x 1mg | Ask for price |
(R)-Crizotinib |
|||
| A3020-10 | ApexBio | 10 mg | EUR 129.6 |
|
Description: Crizotinib is a potent, ATP-competitive, small-molecule and orally available inhibitor of c-Met kinase with a Ki value of 4 nmol/L[1].Crizotinib has shown to inhibit wild-type c-Met phosphorylation with a mean IC50 value of 11 nmol/L in multiple human endothelial and carcinoma cell lines. |
|||
(R)-Crizotinib |
|||
| A3020-100 | ApexBio | 100 mg | EUR 254.4 |
|
Description: Crizotinib is a potent, ATP-competitive, small-molecule and orally available inhibitor of c-Met kinase with a Ki value of 4 nmol/L[1].Crizotinib has shown to inhibit wild-type c-Met phosphorylation with a mean IC50 value of 11 nmol/L in multiple human endothelial and carcinoma cell lines. |
|||
(R)-Crizotinib |
|||
| A3020-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 164.4 |
|
Description: Crizotinib is a potent, ATP-competitive, small-molecule and orally available inhibitor of c-Met kinase with a Ki value of 4 nmol/L[1].Crizotinib has shown to inhibit wild-type c-Met phosphorylation with a mean IC50 value of 11 nmol/L in multiple human endothelial and carcinoma cell lines. |
|||
(R)-Crizotinib |
|||
| A3020-50 | ApexBio | 50 mg | EUR 199.2 |
|
Description: Crizotinib is a potent, ATP-competitive, small-molecule and orally available inhibitor of c-Met kinase with a Ki value of 4 nmol/L[1].Crizotinib has shown to inhibit wild-type c-Met phosphorylation with a mean IC50 value of 11 nmol/L in multiple human endothelial and carcinoma cell lines. |
|||
(R)-Crizotinib |
|||
| A3020-S | ApexBio | Evaluation Sample | EUR 97.2 |
|
Description: Crizotinib is a potent, ATP-competitive, small-molecule and orally available inhibitor of c-Met kinase with a Ki value of 4 nmol/L[1].Crizotinib has shown to inhibit wild-type c-Met phosphorylation with a mean IC50 value of 11 nmol/L in multiple human endothelial and carcinoma cell lines. |
|||
R(-)-Gossypol |
|||
| 20-abx076641 | Abbexa |
|
|
(R)-Methyglycidate |
|||
| 20-abx181457 | Abbexa |
|
|
(R)-(-)-Epichlorohydrin |
|||
| abx182749-25g | Abbexa | 25 g | EUR 243.6 |
R-(+)-Lansoprazole |
|||
| 20-abx186556 | Abbexa |
|
|
(R)-Bicalutamide |
|||
| BC1004-050 | GenDepot | 50mg | EUR 230.4 |
(R)-Bicalutamide |
|||
| BC1004-100 | GenDepot | 100mg | EUR 295.2 |
(R)-Bicalutamide |
|||
| BC1004-250 | GenDepot | 250mg | EUR 472.8 |
×